ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,363 | -99.4% | 19,096 | -97.4% | 0.00% | -100.0% |
| Q3 2022 | $4,843,000 | +5.1% | 722,943 | -0.2% | 0.09% | -27.6% |
| Q2 2022 | $4,608,000 | +223.8% | 724,454 | +136.2% | 0.13% | +234.2% |
| Q1 2022 | $1,423,000 | +77.0% | 306,681 | +90.8% | 0.04% | +52.0% |
| Q4 2021 | $804,000 | -74.6% | 160,749 | +202.7% | 0.02% | -87.8% |
| Q4 2019 | $3,166,000 | -10.6% | 53,100 | -45.0% | 0.20% | -2.8% |
| Q3 2019 | $3,541,000 | +1357.2% | 96,600 | +1747.4% | 0.21% | +681.5% |
| Q2 2019 | $243,000 | -78.5% | 5,229 | -81.5% | 0.03% | -85.5% |
| Q1 2019 | $1,132,000 | – | 28,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |